Citation: | Liu Qiu-ju, Cao Jing-yuan, Lu Guo-yuan. Establishing and validating a risk prediction model for acute kidney injury in patients with acute heart failure[J]. Journal of Clinical Nephrology, 2021, 21(6): 485-492. DOI: 10.3969/j.issn.1671-2390.m20-224 |
[1] |
Ponikowski P,Voors AA,Anker SD,et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J].Eur Heart J,2016,37(27):2129-2200.DOI: 10.1093/eurheartj/ehw128.
|
[2] |
Ronco C,Di Lullo L.Cardiorenal syndrome in western countries:epidemiology,diagnosis and management approaches[J].Kidney Dis(Basel),2017,2(4):151-163.DOI: 10.1159/000448749.
|
[3] |
Rastogi A,Fonarow GC.The cardiorenal connection in heart failure[J].Curr Cardiol Rep,2008,10(3):190-197.DOI: 10.1007/s11886-008-0033-1.
|
[4] |
Vandenberghe W,Gevaert S,Kellum JA,et al.Acute kidney injury in cardiorenal syndrome type 1 patients:a systematic review and meta-analysis[J].Cardiorenal Med,2016,6(2):116-128.DOI: 10.1159/000442300.
|
[5] |
Akhter MW,Aronson D,Bitar F,et al.Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure[J].Am J Cardiol,2004,94(7):957-960.DOI: 10.1016/j.amjcard.2004.06.041.
|
[6] |
王银娜,越桐,程虹,等.急性心力衰竭患者发生1型心肾综合征的风险预警评分[J].临床心血管病杂志,2014,30(6):506-508.DOI: 10.13201/j.issn.1001-1439.2014.06.013.
Wang YN,Yue T,Cheng H,et al.Prediction risk score for type 1 cardiorenal syndrome in patients with acute heart failure[J].J Clin Cardiol,2014,30(6):506-508.DOI: 10.13201/j.issn.1001-1439.2014.06.013.
|
[7] |
Zhou LZ,Yang XB,Guan Y,et al.Development and validation of a risk score for prediction of acute kidney injury in patients with acute decompensated heart failure:a prospective cohort study in China[J].J Am Heart Assoc,2016,5(11):e004035.DOI: 10.1161/JAHA.116.004035.
|
[8] |
Fan ZY,Li Y,Ji HH,et al.Nomogram model to predict cardiorenal syndrome type 1 in patients with acute heart failure[J].Kidney Blood Press Res,2018,43(6):1832-1841.DOI: 10.1159/000495815.
|
[9] |
The ad-hoc working group of ERBP,Fliser D,Laville M,et al.A European Renal Best Practice(ERBP)position statement on the Kidney Disease Improving Global Outcomes(KDIGO)Clinical Practice Guidelines on Acute Kidney Injury:Part 1:definitions,conservative management and contrast-induced nephropathy[J].Nephrol Dial Transplant,2012,27(12):4263-4272.DOI: 10.1093/ndt/gfs375.
|
[10] |
Fortescue EB,Kahn K,Bates DW.Development and validation of a clinicalprediction rule for major adverse outcomes in coronary bypass grafting[J].Am J Cardiol,2001,88(11):1251-1258.DOI: 10.1016/s0002-9149(01)02086-0.
|
[11] |
Bock JS,Gottlieb SS.Cardiorenal syndrome new perspectives[J].Circulation,2010,121(23):2592-600.DOI: 10.1161/CIRCULATIONAHA.109.886473.
|
[12] |
许书添,李世军.肾静脉高压与急性肾损伤[J].肾脏病与透析肾移植杂志,2015,24(6):557-561.
Xu ST,Li SJ.Relationship between renal venous hypertension and acute kidney injury[J].Chin J Nephrol Dial Transplant,2015,24(6):557-561.
|
[13] |
Virzì GM,Torregrossa R,Cruz DN,et al.Cardiorenal syndrome type 1 may be immunologically mediated:a pilot evaluation of monocyte apoptosis[J].Cardiorenal Med,2012,2(1):33-42.DOI: 10.1159/000335499.
|
[14] |
Pastori S,Virzì GM,Brocca A,et al.Cardiorenal syndrome type 1:activation of dual apoptotic pathways[J].Cardiorenal Med,2015,5(4):306-315.DOI: 10.1159/000438831.
|
[15] |
Virzì GM,Clementi A,de Cal M,et al.Oxidative stress:dual pathway induction in cardiorenal syndrome type 1 pathogenesis[J].Oxid Med Cell Longev,2015,2015:391790.DOI: 10.1155/2015/391790.
|
[16] |
Chawla LS,Eggers PW,Star RA,et al.Acute kidney injury and chronic kidney disease as interconnected syndromes[J].N Engl J Med,2014,371(1):58-66.DOI: 10.1056/NEJMra1214243.
|
[17] |
Khoundabi B,Kazemnejad A,Mansourian M,et al.Acute kidney injury risk factors for ICU patients following cardiac surgery:the application of joint modeling[J].Trauma Mon,2016,21(4):e23749.DOI: 10.5812/traumamon.23749.
|
[18] |
Gerstein HC,Pogue J,Mann JF,et al.The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study:a prospective epidemiological analysis[J].Diabetologia,2005,48(9):1749-1755.DOI: 10.1007/s00125-005-1858-4.
|
[19] |
Levitan EB,Song YQ,Ford ES,et al.Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies[J].Arch Intern Med,2004,164(19):2147-2155.DOI: 10.1001/archinte.164.19.2147.
|
[20] |
Jankowska EA,Ponikowska B,Majda J,et al.Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure[J].Int J Cardiol,2007,115(2):151-155.DOI: 10.1016/j.ijcard.2005.10.033.
|
[21] |
Hu WX,He WN,Liu W,et al.Risk factors and prognosis of cardiorenal syndrome type 1 in elderly Chinese patients:a retrospective observational cohort study[J].Kidney Blood Press Res,2016,41(6):1037.DOI: 10.1159/000452596.
|
[22] |
Do C.Intravenous contrast:friend or foe? A review on contrast-induced nephropathy[J].Adv Chronic Kidney Dis,2017,24(3):147-149.DOI: 10.1053/j.ackd.2017.03.003.
|